Intravesical Therapy of Superficial Bladder Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|3|345-359

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.3, 2000-02, pp. : 345-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical therapy for bladder cancer

By Williams Steve K   Hoenig David M   Ghavamian Reza   Soloway Mark  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 947-958

Informa Healthcare

Access to resources Recommend Favorite

Epirubicin: A Review of its Intravesical Use in Superficial Bladder Cancer

By Onrust S.V.   Wiseman L.R.   Goa K.L.  

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 307-333

Adis International

Access to resources Recommend Favorite

Intravesical valrubicin for bladder cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

The Effects of Intravesical Chemoimmunotherapy with Gemcitabine and Bacillus Calmette–Guérin in Superficial Bladder Cancer: a Preliminary Study

By Cho DY   Bae JH   Moon DG   Cheon J   Lee JG   Kim JJ   Yoon DK   Park HS  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1823-1830

Field House Publishing

Access to resources Recommend Favorite